Glycosaminoglycans in biomedicine

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 4, 2013, Pages 388-398

  Scott, Rebecca A ^a   Panitch, Alyssa ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL ASSEMBLY; EXTRACELLULAR MATRICES; GLYCOSAMINOGLYCANS; HIGH-THROUGHPUT METHOD; PLATELET ADHESION; PROTEOLYTIC ACTIVITIES; REGENERATIVE MEDICINE; SCREENING METHODS;

BIOPOLYMERS; GLYCOPROTEINS; MAMMALS; MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY; STIFFNESS MATRIX; TISSUE ENGINEERING;

DIAGNOSIS;

AGGRECAN; BIOPOLYMER; BOVINE SERUM ALBUMIN; CHONDROITIN 4 SULFATE; CHONDROITIN SULFATE; COLLAGEN FIBRIL; DECORIN; DERMATAN SULFATE; FIBROBLAST GROWTH FACTOR; GLYCOLIPID; GLYCOSAMINOGLYCAN; HEPARIN; MUCIN; NANOPARTICLE; POLYACRYLIC ACID; PROTEOGLYCAN; VASCULOTROPIN;

ARTICLE; BINDING AFFINITY; BIOMEDICINE; CHEMICAL MODIFICATION; CONTROLLED DRUG RELEASE; DRUG TARGETING; EXTRACELLULAR MATRIX; GLYCOCALYX; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR INTERACTION; NANOMEDICINE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC PRESSURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGENERATIVE MEDICINE; SEQUENCE ANALYSIS; SYNTHESIS; THROMBOCYTE ADHESION; TISSUE ENGINEERING;

ANIMALS; BIOMEDICAL RESEARCH; GLYCOLIPIDS; GLYCOSAMINOGLYCANS; HUMANS; MOLECULAR MIMICRY; PROTEOGLYCANS;

EID: 84879231881     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1223     Document Type: Article

References (58)

1. Larsen K, Thygesen MB, Guillaumie F, Willats WGT, Jensen KJ. Solid-phase chemical tools for glycobiology. Carbohydr Res 2006, 341:1209-1234.
2. Noti C, Seeberger PH. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans. Chem Biol 2005, 12: 731-756.
3. Hart GW, Copeland RJ. Glycomics hits the big time. Cell 2010, 143:672-676.
4. Vazquez-Dorbatt V, Lee J, Lin EW, Maynard HD. Synthesis of glycopolymers by controlled radical polymerization techniques and their applications. ChemBioChem, 13:2478-2487.
5. Voit B, Appelhans D. Glycopolymers of various architectures-more than mimicking nature. Macromol Chem Phys 2010, 211:727-735.
6. Bedini E, De Castro C, De Rosa M, Di Nola A, Restaino OF, Schiraldi C, Parrilli M. Semi-synthesis of unusual chondroitin sulfate polysaccharides containing GlcA(3-O-sulfate) or GlcA(2, 3-di-O-sulfate) units. Chemistry 2012, 18:2123-2130.
7. Vibert A, Jacquinet Js, Lopin-Bon C. Recent advances in the chemical and enzymatic chondroitin sulfate synthesis. J Carbohydr Chem 2011, 30:393-414.
8. Slavin S, Burns J, Haddleton DM, Becer CR. Synthesis of glycopolymers via click reactions. Eur Polym J 2011, 47:435-446.
9. Gemma E, Meyer O, Uhrin D, Hulme AN. Enabling methodology for the end functionalisation of glycosaminoglycan oligosaccharides. Mol Biosyst 2008, 4:481-495.
10. DeAngelis P. Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl Microbiol Biotechnol 2012, 94:295-305.
11. Jia X, Kiick KL. Hybrid multicomponent hydrogels for tissue engineering. Macromol Biosci 2009, 9:140-156.
12. Baldwin AD, Kiick KL. Polysaccharide-modified synthetic polymeric biomaterials. Pept Sci 2010, 94:128-140.
13. Hudalla GA, Murphy WL. Biomaterials that regulate growth factor activity via bioinspired interactions. Adv Funct Mater, 21:1754-1768.
14. Ferdous Z, Grande-Allen KJ. Utility and control of proteoglycans in tissue engineering. Tissue Eng 2007, 13:1893-1904.
15. Yannas IV, Tzeranis DS, Harley BA, So PT. Biologically active collagen-based scaffolds: advances in processing and characterization. Philos Transact A Math Phys Eng Sci 2010, 368:2123-2139.
16. Lee SG. End-functionalized glycopolymers as mimetics of chondroitin sulfate proteoglycans. Chem Sci 2010, 1:322.
17. Raman R, Sasisekharan R. Cooperativity in glycan-protein interactions. Chem Biol 2007, 14:873-874.
18. Tomita N, Sando S, Sera T, Aoyama Y. Macrocyclic proteoglycan mimics. Potent inhibition of cell adhesion by a bundle of chondroitin sulfate chains assembled on the calix[4]resorcarene platform. Bioorg Med Chem Lett 2004, 14:2087-2090.
19. Bae J, Desai UR, Pervin A, Caldwell EE, Weiler JM, Linhardt RJ. Interaction of heparin with synthetic antithrombin III peptide analogues. Biochem J 1994, 301:121-129.
20. de Paz JL, Seeberger PH. Deciphering the glycosaminoglycan code with the help of microarrays. Mol Biosyst 2008, 4:707-711.
21. Takada W, Fukushima M, Pothacharoen P, Kongtawelert P, Sugahara K. A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies. Anal Biochem 2013, 435:123-130.
22. Dernedde J, Papp I, Enders S, Wedepohl S, Paulus F, Haag R. Synthesis and evaluation of nonsulfated and sulfated glycopolymers as L- and P-selectin inhibitors. J Carbohyd Chem 2011, 30:347-360.
23. Oezyuerek Z, Franke K, Nitschke M, Schulze R, Simon F, Eichhorn KJ, Pompe T, Werner C, Voit B. Sulfated glyco-block copolymers with specific receptor and growth factor binding to support cell adhesion and proliferation. Biomaterials 2009, 30: 1026-1035.
24. Cerrada ML, Ruiz C, Sánchez-Chaves M, Fernández-García M. Molecular recognition capability and rheological behavior in solution of novel lactone-based glycopolymers. Eur Polym J 2009, 45:3176-3186.
25. Ahmed M, Lai BFL, Kizhakkedathu JN, Narain R. Hyperbranched glycopolymers for blood biocompatibility. Bioconjug Chem 2012, 23:1050-1058.
26. Besenius P, Slavin S, Vilela F, Sherrington DC. Synthesis and characterization of water-soluble densely branched glycopolymers. Reactive Funct Polym 2008, 68:1524-1533.
27. Miura Y. Synthesis and biological application of glycopolymers. J Polym Sci [A] 2007, 45:5031-5036.
28. Hahn SK, Jelacic S, Maier RV, Stayton PS, Hoffman AS. Anti-inflammatory drug delivery from hyaluronic acid hydrogels. J Biomater Sci Polym Ed 2004, 15:1111-1119.
29. Cai C, Solakyildirim K, Yang B, Beaudet JM, Weyers A, Linhardt RJ, Zhang F. Semi-synthesis of chondroitin sulfate-E from chondroitin sulfate-A. Carbohyd Polym 2012, 87:822-829.
30. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed 2002, 41:390-412.
31. Pan J, Qian Y, Zhou X, Lu H, Ramacciotti E, Zhang L. Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways. J Biol Chem 2010, 285:22966-22975.
32. Satoh T, Nishiyama K, Nagahata M, Teramoto A, Abe K. The research on physiological property of functionalized hyaluronan: interaction between sulfated hyaluronan and plasma proteins. Polym Adv Technol 2004, 15:720-725.
33. Freeman I, Kedem A, Cohen S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 2008, 29:3260-3268.
34. Cai S, Liu Y, Zheng Shu X, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005, 26:6054-6067.
35. Ilgin P, Avci G, Silan C, Ekici S, Aktas N, Ayyala RS, John VT, Sahiner N. Colloidal drug carries from (sub)micron hyaluronic acid hydrogel particles with tunable properties for biomedical applications. Carbohydr Polym 2010, 82:997-1003.
36. Möller S, Schmidtke M, Weiss D, Schiller J, Pawlik K, Wutzler P, Schnabelrauch M. Synthesis and antiherpetic activity of carboxymethylated and sulfated hyaluronan derivatives. Carbohydr Polym 2012, 90:608-615.
37. Eng D, Caplan M, Preul M, Panitch A. Hyaluronan scaffolds: a balance between backbone functionalization and bioactivity. Acta Biomater 2010, 6: 2407-2414.
38. Li Q, Williams CG, Sun DDN, Wang J, Leong K, Elisseeff JH. Photocrosslinkable polysaccharides based on chondroitin sulfate. J Biomed Mater Res A 2004, 68A:28-33.
39. Nie T, Akins RE, Kiick KL. Production of heparin-containing hydrogels for modulating cell responses. Acta Biomater 2009, 5:865-875.
40. Zhang L, Furst EM, Kiick KL. Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions. J Control Release 2006, 114:130-142.
41. Benoit DSW, Anseth KS. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 2005, 1:461-470.
42. Aulin C, Bergman K, Jensen-Waern M, Hedenqvist P, Hilborn J, Engstrand T. In situ cross-linkable hyaluronan hydrogel enhances chondrogenesis. J Tissue Eng Regen Med 2011, 5:188-196.
43. Tae G, Kim Y-J, Choi W-I, Kim M, Stayton PS, Hoffman AS. Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules. Biomacromolecules 2007, 8:1979-1986.
44. Yamaguchi N, Zhang L, Chae B-S, Palla CS, Furst EM, Kiick KL. Growth factor mediated assembly of cell receptor-responsive hydrogels. J Am Chem Soc 2007, 129:3040-3041.
45. Tan H, Zhou Q, Qi H, Zhu D, Ma X, Xiong D. Heparin interacting protein mediated assembly of nano-fibrous hydrogel scaffolds for guided stem cell differentiation. Macromol Biosci 2012, 12: 621-627.
46. Satoh T, Nagahata M, Teramoto A, Hatimori A, Abe K, Im SS. The basic research on physiological property of functionalized hyaluronan-I. Effect of hyaluronan and sulfated hyaluronan on cell proliferation of human epidermal keratinocytes. Polym Adv Technol 2004, 15:329-334.
47. Papy-Garcia D, Barbier-Chassefière V, Rouet V, Kerros M-E, Klochendler C, Tournaire MC, Barritault D, Caruelle JP, Petit E. Nondegradative sulfation of polysaccharides. Synthesis and structure characterization of biologically active heparan sulfate mimetics. Macromolecules 2005, 38:4647-4654.
48. Ruhela D, Riviere K, Szoka FC. Efficient synthesis of an aldehyde functionalized hyaluronic acid and its application in the preparation of hyaluronan-lipid conjugates. Bioconjug Chem 2006, 17:1360-1363.
49. Pumphrey CY, Theus AM, Li S, Parrish RS, Sanderson RD. Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 2002, 62:3722-3728.
50. Han E, Wilensky LM, Schumacher BL, Chen AC, Masuda K, Sah RL. Tissue engineering by molecular disassembly and reassembly: biomimetic retention of mechanically functional aggrecan in hydrogel. Tissue Eng Part C Methods 2012, 16:1471-1479.
51. Jin R, Moreira Teixeira LS, Dijkstra PJ, van Blitterswijk CA, Karperien M, Feijen J. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 2010, 31:3103-3113.
52. Prudnikova K, Vresilovic EJ, Marcolongo M. New strategy for treatment of lower back pain: molecular restoration of intervertebral disc using an injection of biomimetic aggrecan. Spine J 2012, 12:S30.
53. Paderi JE, Sistiabudi R, Ivanisevic A, Panitch A. Collagen-binding peptidoglycans: a biomimetic approach to modulate collagen fibrillogenesis for tissue engineering applications. Tissue Eng Part A. 2009, 15: 2991-2999.
54. Stuart KA, Paderi JE, Snyder P, Freeman L, Panitch A. Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring. PLoS One 2011, 6:e22139.
55. Bernhard JC, Panitch A. Synthesis and characterization of an aggrecan mimic. Acta Biomater 2012, 8:1543-1550.
56. Sharma S, Panitch A, Neu CP. Incorporation of an aggrecan mimic prevents proteolytic degradation of anisotropic cartilage analogs. Acta Biomater 2013, 9:4618-4625.
57. Saxon E, Bertozzi CR. Chemical and biological strategies for engineering cell surface glycosylation. Annu Rev Cell Dev Biol 2001, 17:1-23.
58. Paderi JE, Stuart K, Sturek M, Park K, Panitch A. The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. Biomaterials 2011, 32: 2516-2523.